Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India

被引：11
作者：
Murray, Henry W. [1 ]
机构：
[1] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
来源：
FUTURE MICROBIOLOGY | 2010年 / 5卷 / 09期
关键词：
LIPOSOMAL AMPHOTERICIN-B; MILTEFOSINE;
D O I：
10.2217/FMB.10.92
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：1301 / 1303
页数：3
相关论文
共 12 条
[1]   Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis [J].
Bhattacharya, Sujit Kumar ;
Sinha, Prabhat Kumar ;
Sundar, Shyam ;
Thakur, Chandreshar Prasad ;
Jha, Tara Kant ;
Pandey, Krishna ;
Das, Vidyanand Rabi ;
Kumar, Naveen ;
Lal, Chandrasekhar ;
Verma, Neena ;
Singh, Vijay Pratap ;
Ranjan, Alok ;
Verma, Rakesh Bihari ;
Anders, Gerlind ;
Sindermann, Herbert ;
Ganguly, Nirmal Kumar .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (04) :591-598
[2]   Developments in the treatment of visceral leishmaniasis [J].
den Boer, Margriet Leontine ;
Alvar, Jorge ;
Davidson, Robert N. ;
Ritmeijer, Koert ;
Balasegaram, Manica .
EXPERT OPINION ON EMERGING DRUGS, 2009, 14 (03) :395-410
[3]   Visceral Leishmaniasis Elimination Programme in India, Bangladesh, and Nepal: Reshaping the Case Finding/Case Management Strategy [J].
Mondal, Dinesh ;
Singh, Shri Prakash ;
Kumar, Narendra ;
Joshi, Anand ;
Sundar, Shyam ;
Das, Pradeep ;
Siddhivinayak, Hirve ;
Kroeger, Axel ;
Boelaert, Marleen .
PLOS NEGLECTED TROPICAL DISEASES, 2009, 3 (01)
[4]   Advances in leishmaniasis [J].
Murray, HW ;
Berman, JD ;
Davies, CR ;
Saravia, NG .
LANCET, 2005, 366 (9496) :1561-1577
[5]   Amphotericin B treatment for Indian visceral leishmaniasis: Conventional versus lipid formulations [J].
Sundar, S ;
Mehta, H ;
Suresh, AV ;
Singh, SP ;
Rai, M ;
Murray, HW .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) :377-383
[6]   Oral miltefosine for Indian visceral leishmaniasis [J].
Sundar, S ;
Jha, TK ;
Thakur, CP ;
Engel, J ;
Sindermann, H ;
Fischer, C ;
Junge, K ;
Bryceson, A ;
Berman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (22) :1739-1746
[7]   Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: A multicenter study [J].
Sundar, S ;
Jha, TK ;
Thakur, CP ;
Mishra, M ;
Singh, VP ;
Buffels, R .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2002, 66 (02) :143-146
[8]   New treatment approach in Indian visceral leishmaniasis: Single-dose liposomal amphotericin B followed by short-course oral miltefosine [J].
Sundar, Shyam ;
Rai, M. ;
Chakravarty, J. ;
Agarwal, D. ;
Agrawal, N. ;
Vaillant, Michel ;
Olliaro, Piero ;
Murray, Henry W. .
CLINICAL INFECTIOUS DISEASES, 2008, 47 (08) :1000-1006
[9]   Amphotericin B treatment for Indian visceral leishmaniasis: Response to 15 daily versus alternate-day infusions [J].
Sundar, Shyam ;
Chakravarty, J. ;
Rai, V. K. ;
Agrawal, N. ;
Singh, S. P. ;
Chauhan, V. ;
Murray, Henry W. .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (05) :556-561
[10]   Injectable paromomycin for visceral leishmaniasis in India [J].
Sundar, Shyam ;
Jha, T. K. ;
Thakur, Chandreshwar P. ;
Sinha, Prabhat K. ;
Bhattacharya, Sujit K. ;
Nguyen, B. ;
Kwan, E. ;
Oudin, A. ;
Valcke, K. ;
Mathie, S. ;
Ley, C. ;
Rosenberg, M. ;
Gaithersburg, E. L. ;
Muenz, L. ;
He, D. ;
Wei, L. J. ;
Ballanchanda, B. ;
Wrone, E. ;
Mahmoud, E. ;
Davidson, R. ;
Sweetow, R. ;
Ballanchanda, B. ;
Valente, M. ;
Sheiner, L. ;
Beal, S. ;
Lin, E. ;
Gee, W. ;
Huang, Y. ;
Chang, H. ;
Li, X. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (25) :2571-2581
12